Maria Judit Molnar

Flag of  |    +3614591492

Maria Judit Molnar MD, PhD, Professor of Neurology, Psychiatry, Clinical Genetics, and Clinico-pharmacology, Doctor of the Hungarian Academy of Sciences is the director of Semmelweis University’s Institute of Genomic Medicine and Rare Disorders, among others president of the Hungarian Medical College of Clinical Genetics, past president of the Hungarian Society of Clinical Neurogenetics, secretary of the Hungarian Society of Personalized Medicine, board member of the Neurogenetic and Neuromuscular Committee of the European Academy of Neurology. She was the vice-rector for Scientific Affairs at Semmelweis University (Budapest, Hungary) between 2012 and 2015, where she was also responsible for International Affairs. She has been adjunct professor at the Montreal Neurological Institute, McGill University, since 1999. Dr. Molnar is the Leader of a Challenge Group of the International Consortia of Person alized Medicine initiated by the European Commission. She is the member of the steering committee of the Association of Academic Health Centers International. Dr. Molnar is recognized as a leading experts on the diagnosis and treatment of rare neurological especially rare neurogenetic (neuromuscular) disorders. The Institute of Genomic Medicine and Rare Disorders lead by her offers a comprehensive state of the art, patient-centered care for patients with rare neurological disorders including genetic testing, neuropathological investigations and genetic counselling as well. Dr. Molnar’s research covers a broad range of basic and clinical studies on rare neurological disorders, utilizing a broad spectrum of technologies including clinical science, histology, cytochemistry, molecular biology and genetics. She plays important role in the organization of rare disease management in Hungary and acts as an ambassador promoting the personalized healthcare.

Woman Profile Photo

Healthcare Provider

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit